KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Return on Invested Capital: 2025

Historic Return on Invested Capital for Rigel Pharmaceuticals (RIGL) over the last 1 years, with Sep 2025 value amounting to 0.94%.

  • Rigel Pharmaceuticals' Return on Invested Capital was N/A to 0.94% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.94%, marking a year-over-year change of. This contributed to the annual value of -4.24% for FY2024, which is N/A change from last year.
  • As of Q3 2025, Rigel Pharmaceuticals' Return on Invested Capital stood at 0.94%, which was down 37.57% from 1.50% recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Return on Invested Capital registered a high of 1.96% during Q1 2025, and its lowest value of 0.94% during Q3 2025.
  • Moreover, its 1-year median value for Return on Invested Capital was 1.50% (2025), whereas its average is 1.47%.